|
| Timo Gaiser | Vrije Universiteit Medical Center Gerrit A. Meijer, Netherlands Cancer Institute Cornelis J.A. Punt, Academic Medical Center, University Medical Center Utrecht, Royal College of Surgeons in Ireland Verena Murphy, Beaumont Hospital Bozena Fender and William M. Gallagher, OncoMark Ltd Rut Klinger and William M. Gallagher, University College Dublin, University Hospital Mannheim, Veneto Institute of Oncology IOV-IRCCS Padua |
| Timo Gaiser | Vrije Universiteit Medical Center Gerrit A. Meijer, Netherlands Cancer Institute Cornelis J.A. Punt, Academic Medical Center, University Medical Center Utrecht, Royal College of Surgeons in Ireland Verena Murphy, Beaumont Hospital Bozena Fender and William M. Gallagher, OncoMark Ltd Rut Klinger and William M. Gallagher, University College Dublin, University Hospital Mannheim, Veneto Institute of Oncology IOV-IRCCS Padua |
| Gerrit A Meijer | Vrije Universiteit Medical Center Gerrit A. Meijer, Netherlands Cancer Institute Cornelis J.A. Punt, Academic Medical Center, University Medical Center Utrecht, Royal College of Surgeons in Ireland Verena Murphy, Beaumont Hospital Bozena Fender and William M. Gallagher, OncoMark Ltd Rut Klinger and William M. Gallagher, University College Dublin, University Hospital Mannheim, Veneto Institute of Oncology IOV-IRCCS Padua |
| Rut Klinger | Vrije Universiteit Medical Center Gerrit A. Meijer, Netherlands Cancer Institute Cornelis J.A. Punt, Academic Medical Center, University Medical Center Utrecht, Royal College of Surgeons in Ireland Verena Murphy, Beaumont Hospital Bozena Fender and William M. Gallagher, OncoMark Ltd Rut Klinger and William M. Gallagher, University College Dublin, University Hospital Mannheim, Veneto Institute of Oncology IOV-IRCCS Padua |
| William M Gallagher | Vrije Universiteit Medical Center Gerrit A. Meijer, Netherlands Cancer Institute Cornelis J.A. Punt, Academic Medical Center, University Medical Center Utrecht, Royal College of Surgeons in Ireland Verena Murphy, Beaumont Hospital Bozena Fender and William M. Gallagher, OncoMark Ltd Rut Klinger and William M. Gallagher, University College Dublin, University Hospital Mannheim, Veneto Institute of Oncology IOV-IRCCS Padua |
| Darran P O'Connor | Vrije Universiteit Medical Center Gerrit A. Meijer, Netherlands Cancer Institute Cornelis J.A. Punt, Academic Medical Center, University Medical Center Utrecht, Royal College of Surgeons in Ireland Verena Murphy, Beaumont Hospital Bozena Fender and William M. Gallagher, OncoMark Ltd Rut Klinger and William M. Gallagher, University College Dublin, University Hospital Mannheim, Veneto Institute of Oncology IOV-IRCCS Padua |
| Diether Lambrechts | Vrije Universiteit Medical Center Gerrit A. Meijer, Netherlands Cancer Institute Cornelis J.A. Punt, Academic Medical Center, University Medical Center Utrecht, Royal College of Surgeons in Ireland Verena Murphy, Beaumont Hospital Bozena Fender and William M. Gallagher, OncoMark Ltd Rut Klinger and William M. Gallagher, University College Dublin, University Hospital Mannheim, Veneto Institute of Oncology IOV-IRCCS Padua |
| Annette T Byrne | Vrije Universiteit Medical Center Gerrit A. Meijer, Netherlands Cancer Institute Cornelis J.A. Punt, Academic Medical Center, University Medical Center Utrecht, Royal College of Surgeons in Ireland Verena Murphy, Beaumont Hospital Bozena Fender and William M. Gallagher, OncoMark Ltd Rut Klinger and William M. Gallagher, University College Dublin, University Hospital Mannheim, Veneto Institute of Oncology IOV-IRCCS Padua |
| Bauke Ylstra | Vrije Universiteit Medical Center Gerrit A. Meijer, Netherlands Cancer Institute Cornelis J.A. Punt, Academic Medical Center, University Medical Center Utrecht, Royal College of Surgeons in Ireland Verena Murphy, Beaumont Hospital Bozena Fender and William M. Gallagher, OncoMark Ltd Rut Klinger and William M. Gallagher, University College Dublin, University Hospital Mannheim, Veneto Institute of Oncology IOV-IRCCS Padua |